Background

Content Library

Filter
Type
Topic
Product
  • Publication
  • Sep 7, 2018
Acylguanidine Beta Secretase 1 Inhibitors: A Combined Experimental and Free Energy Perturbation Study
Ker’nen, et al. J. Chem. Theory Comput., 2017, 13, 1439-1453
  • Publication
  • Sep 7, 2018
Advancing Drug Discovery through Enhanced Free Energy Calculations
Abel, et al. Acc. Chem. Res., 2017, 50, 1625-1632
  • Publication
  • Apr 27, 2018
High throughput evaluation of macrocyclization strategies for conformer stabilization
Sindhikara, et al. Nature, Scientific Reports, 2018, 8 (6585), doi:10.1038/s41598-018-24766-5
  • Publication
  • Mar 23, 2018
Predicting Binding Free Energies of PDE2 Inhibitors. The Difficulties of Protein Conformation
P’rez-Benito, et al. Nature, Scientific Reports, 2018, 8 (4883), doi:10.1038/s41598-018-23039-5
  • Publication
  • Jul 13, 2017
A New Mixed All-Atom/Coarse-Grained Model: Application to Melittin Aggregation in Aqueous Solution
Shelley, et al. J. Chem. Theory Comput., 2017, 13 (8), 3881-3897
  • Publication
  • Jun 21, 2017
Calculating Water Thermodynamics in the Binding Site of Proteins – Applications of WaterMap to Drug Discovery
Cappel, et al. Curr Top Med Chem., 2017, 17 (23), 2586-2598
  • Publication
  • Jun 15, 2017
A Comparison of Quantum and Molecular Mechanical Methods to Estimate Strain Energy in Drug-like Fragments
Sellers, et al. J. Chem. Inf. Model., 2017, 57 (6), 1265-1275
  • Publication
  • Mar 29, 2017
Free Energy Perturbation Calculations of the Thermodynamics of Protein Side-Chain Mutations
Steinbrecher, et al. J. Mol. Biol., 2017, 429 (7), 923-929
  • Publication
  • Mar 15, 2017
Prospective Evaluation of Free Energy Calculations for the Prioritization of Cathepsin L Inhibitors
Kuhn, et al. J. Med. Chem., 2017, 60 (6), 2485-2497
  • Publication
  • Nov 28, 2016
Relative Binding Free Energy Calculations Applied to Protein Homology Models
Cappel, et al. J. Chem. Inf. Model., 2016, 56 (12), 2388-2400
  • Publication
  • Dec 16, 2015
OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins
Harder, et al. J. Chem. Theory Comput., 2016, 2 (1), 281-296
dark theme background

Latest insights from Extrapolations blog

With FEP+, “The Experiment is the Limit.”
With FEP+, “The Experiment is the Limit.”

Over the past century, small molecule drugs have represented the dominant modality in drug research, enabling medical breakthroughs that have saved countless lives.

Tackling Drug Solubility: AbbVie and Schrödinger Collaborate to Advance Accurate Prediction Methods (FEP)
Tackling Drug Solubility: AbbVie and Schrödinger Collaborate to Advance Accurate Prediction Methods

The complexity and size of drug candidates has grown in recent years as scientists pursue novel targets once considered undruggable.

Can AlphaFold Models be Used for Structure-Based Drug Design? A Perspective Two Years In Blog
Can AlphaFold Models be Used for Structure-Based Drug Design? A Perspective Two Years In

We recently sat down with Edward Miller, Senior Director of Protein Structure Modeling at Schrödinger, to discuss his experience using AlphaFold models for SBDD.

Training & Resources

Online certification courses

Level up your skill set with hands-on, online molecular modeling courses. These self-paced courses cover a range of scientific topics and include access to Schrödinger software and support.

Free learning resources

Learn how to deploy the technology and best practices of Schrödinger software for your project success. Find training resources, tutorials, quick start guides, videos, and more.